| Autor: |
Nezih Onur Ermerak, Sehnaz Olgun Yildizeli, Derya Kocakaya, Bulent Mutlu, Koray Ak, Serpil Tas, Bedrettin Yildizeli |
| Přispěvatelé: |
Ermerak N. O., Olgun Yildizeli S., Kocakaya D., Mutlu B., Ak K., Gezer Tas S. |
| Jazyk: |
angličtina |
| Rok vydání: |
2023 |
| Předmět: |
|
| Popis: |
Background Coronavirus disease 2019 (COVID-19) is still an ongoing entity and every day we face new sequalae of the disease. We hereby present surgical results of patients who are treated for post-COVID chronic thromboembolic pulmonary hypertension. Methods Data were collected among patients who underwent pulmonary endarterectomy and had a diagnosis of post-COVID chronic thromboembolic pulmonary hypertension. All data were retrospectively reviewed from a prospectively conducted database. Operative mortality was described as death in hospital or within 30 days of surgery. Results Eleven patients (seven males, four females; median age, 52 [22–63] years) were identified. Pulmonary vascular resistance improved significantly from 572 dyn/s/cm−5 (240–1,192) to 240 (195–377) dyn/s/cm−5 (p Conclusions In the new era of chronic thromboembolic pulmonary hypertension, hybrid approach including surgery, balloon pulmonary angioplasty, and medical treatment has been recommended. pulmonary endarterectomy is still the only curative treatment when the disease is surgically accessible. We hereby report the first publication of post-COVID chronic thromboembolic pulmonary hypertension patients who were surgically treated. As we see a lot of long-term symptoms and clinical manifestations in patients who had COVID-19, we should always remember chronic thromboembolic pulmonary hypertension in the differential diagnosis. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
